Trefely Sophie, Doan Mary T, Snyder Nathaniel W
A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, United States; Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.
A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA, United States.
Methods Enzymol. 2019;626:1-21. doi: 10.1016/bs.mie.2019.07.013. Epub 2019 Aug 12.
Dynamic interplay between cellular metabolism and histone acetylation is a key mechanism underlying metabolic control of epigenetics. In particular, the central metabolite acetyl-coenzyme A (acetyl-CoA) acts as the acetyl-donor for histone acetylation in both an enzymatic and non-enzymatic manner. Since members of the family of histone acetyl transferases (HATs) that catalyze the acetylation of histone tails possess a Michaelis constant (Km) within the range of physiological cellular acetyl-CoA concentrations, changing concentrations of acetyl-CoA can restrict or promote enzymatic histone acetylation. Likewise, non-enzymatic histone acetylation occurs at physiological concentrations. These concepts implicate acetyl-CoA as a rheostat for nutrient availability acting, in part, by controlling histone acetylation. Histone acetylation is an important epigenetic modification that controls gene expression and acetyl-CoA dependent changes in both histone acetylation and gene expression have been shown in yeast and mammalian systems. However, quantifying the metabolic conditions required to achieve specific changes in histone acetylation is a major challenge. The relationship between acetyl-CoA and histone acetylation may be influenced by a variety of factors including sub-cellular location of metabolites and enzymes, relative quantities of metabolites, and substrate availability/preference. A diversity of substrates can contribute the two-carbon acyl-chain to acetyl-CoA, a number of pathways can create or degrade acetyl-CoA, and only a handful of potential mechanisms for the crosstalk between metabolism and histone acetylation have been explored. The centrality of acetyl-CoA in intermediary metabolism means that acetyl-CoA levels may change, or be resistant to change, in unexpected ways. Thus, quantification of relevant metabolites is critical evidence in understanding how the nutrient rheostat is set in normal and pathological contexts. Coupling metabolite quantitation with isotope tracing to examine fate of specific metabolites is critical to the crosstalk between metabolism and histone acetylation, including but not limited to acetyl-CoA provides necessary context. This chapter provides guidance on experimental design of quantification with isotope dilution and/or tracing of acetyl-CoA within a targeted or highly multiplexed multi-analyte workflow.
细胞代谢与组蛋白乙酰化之间的动态相互作用是表观遗传学代谢控制的关键机制。特别是,中心代谢物乙酰辅酶A(acetyl-CoA)以酶促和非酶促方式作为组蛋白乙酰化的乙酰供体。由于催化组蛋白尾部乙酰化的组蛋白乙酰转移酶(HATs)家族成员的米氏常数(Km)在生理细胞乙酰辅酶A浓度范围内,乙酰辅酶A浓度的变化可以限制或促进酶促组蛋白乙酰化。同样,非酶促组蛋白乙酰化也发生在生理浓度下。这些概念表明乙酰辅酶A是营养可用性的变阻器,部分通过控制组蛋白乙酰化起作用。组蛋白乙酰化是一种重要的表观遗传修饰,可控制基因表达,并且在酵母和哺乳动物系统中已显示出组蛋白乙酰化和基因表达中依赖乙酰辅酶A的变化。然而,量化实现组蛋白乙酰化特定变化所需的代谢条件是一项重大挑战。乙酰辅酶A与组蛋白乙酰化之间的关系可能受到多种因素的影响,包括代谢物和酶的亚细胞定位、代谢物的相对数量以及底物可用性/偏好。多种底物可以为乙酰辅酶A贡献二碳酰基链,许多途径可以产生或降解乙酰辅酶A,并且仅探索了少数代谢与组蛋白乙酰化之间相互作用的潜在机制。乙酰辅酶A在中间代谢中的核心地位意味着乙酰辅酶A水平可能以意想不到的方式发生变化或抵抗变化。因此,相关代谢物的定量是理解在正常和病理情况下如何设置营养变阻器的关键证据。将代谢物定量与同位素示踪相结合以检查特定代谢物的归宿对于代谢与组蛋白乙酰化之间的相互作用至关重要,包括但不限于乙酰辅酶A提供了必要的背景信息。本章提供了在靶向或高度多重多分析物工作流程中使用同位素稀释和/或乙酰辅酶A示踪进行定量实验设计的指导。